Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
The story of cardiovascular implantable electronic devices (CIEDs) started in 1958 with the first pacemaker (PM) implant performed at Karolinska Hospital in Stockolm and evolved with the first implant of an implantable cardioverter-defibrillator (ICD) performed in Baltimore in 1980. Over time the possibilities to benefit patients with arrhythmia disturbances has evolved, and therapy with an electrical device nowadays includes also selected patients with heart failure.
The follow-up of CIEDs is a crucial component of effective and safe delivery of device therapy and must include therapy optimization and individualization, when needed. Currently, in a clinic targeted to follow current CIEDs, the type of devices to check includes PMs, ICDs, devices for cardiac resynchronization therapy (CRT), implantable loop recorders (ILRs), and implantable cardiovascular monitors (ICMs).
A CIED service or CIED follow-up clinic is a center that provides specialized care and training in cardiac pacing and defibrillation with two or more physicians who are specialists in device implantation and management, nurses and/or technical personnel (at least one allied professional with experience in implantable device management), dedicated equipment, including pacing system analyzers, programmers from multiple manufacturers, and access to remote monitoring platforms (on dedicated computers), and computer systems for storage of data. A functional connection to services related to imaging (x-ray, echocardiography and nuclear cardiology) should be available. Moreover, functional connection to heart failure follow-up services must be available, for appropriate decision making in patients with a CIED and specifically a CRT device. Obviously, full resuscitation facilities should be immediately available in the area of the CIED clinic, with an external defibrillator with integrated pacing function.
In the CIED clinic the experience derived from an appropriate volume of cases, related to all types of devices (PMs, ICDs, CRT devices), is required.
The number of CIEDs is increasing worldwide. The Heart Rhythm Society (HRS)/European Heart Rhythm Association (EHRA) Expert Consensus on the Monitoring of CIEDs reported for the year 2006 an estimate of approximately 280,000 PMs and 160,000 ICDs implanted in North America, and of 250,000 PMs and 50,000 ICDs in western and central Europe. Substantial heterogeneity across Europe exists and implant rates for ICDs and CRT devices are still low in Eastern Europe. The worldwide cardiac pacing and ICD survey undertaken for the calendar year 2009 accounted for 1,002,664 PMs, with 737,840 new implants and 264,824 replacements, and 328,027 ICDs, with 222,407 new implants and 105,620 replacements.
According to these numbers, it is clear that follow-up and monitoring CIEDs is associated with an increasing burden of care for specialized centers with a CIED clinic.
As detailed in the HRS/EHRA Expert Consensus on the Monitoring of CIEDs, the goals of CIED follow-up can be broken into four categories: (1) patient, (2) device, (3) disease, and (4) communication, as delineated in Box 43-1 .
Optimize the patient's quality of life
Optimize pacemaker/ICD system function to meet the patient's clinical requirements
Identify new arrhythmic events and take appropriate decisions
Identify patients at risk and initiate appropriate follow-up with field safety corrective action/safety alerts
Triage non-CIED-related health problems and make appropriate referrals
Help patient to solve practical problems related to CIED (driving license, risk of EMI, travelling, etc.)
Document appropriate CIED function
Identify and correct abnormal CIED behavior
Maximize pulse generator longevity while maintaining patient safety
Identify CIED approaching end of battery life, and to organize CIED replacements in a nonemergent manner
Identify leads at risk of failure
Document the nature and frequency of arrhythmias over time and correlate with patient symptoms and determine the appropriateness of CIED response to these arrhythmias
Document (where feasible) hemodynamic status, transthoracic impedance, patient activity and other physiologic parameters over time as part of chronic disease monitoring in heart failure
Monitor the evolution of the underlying heart disease in terms of arrhythmic and hemodynamic profile
Monitor response to therapy
Maintain a patient database
Timely communication to the patient and relevant health care providers of CIED- and disease-related information
Provide technical expertise and education to colleagues, patients, and community
CIED, Cardiac implantable electronic device; EMI, electromagnetic interference; ICD, implantable cardioverter-defibrillator.
Even if the categories and goals of CIED follow-up did not change, the HRS Expert Consensus Statement on Remote Interrogation and Monitoring for Cardiovascular Electronic Implantable Devices released in 2015 substantially magnified the incorporation of remote monitoring into follow-up practice, integrating the option of remote transmission of CIED data with in-office device checks, with a modified frequency. This change is supported by a series of randomized controlled trials that have compared conventional in-person checks versus remote management strategies for the follow-up care of patients with CIEDs, with the results of improved adherence to scheduled evaluations when remote monitoring is adopted.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here